Genome editing -- a next step in genetic therapy -- corrects hemophilia in animals

Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice. This is the first time that genome editing, which precisely targets and repairs a genetic defect, has been done in a living animal and achieved clinically meaningful results.

Read the whole article on Science Daily

More from Science Daily